Article

Xeno-nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding

2021-07-14

Abstract excerpt

The causative agent of COVID-19, SARS-CoV-2, gains access to cells through interactions of the receptor binding domain (RBD) on the viral S protein with angiotensin converting enzyme 2 (ACE2) on the surface of human host cells. Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was used to generate aptamers (nucleic acids selected for high binding affinity to a target) to the RBD made from 2’-fluoro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 20e77c32-1b95-5902-8fea-a7c27ea14f8d
DOI: 10.1101/2021.07.13.452259

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Xeno-nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 BindingDOI 10.1101/2021.07.13.452259Read

Inhibition of SARS-CoV-2 Infection in Human Airway Epithelium with a Xeno-Nucleic Acid AptamerSemantic proximity Read

Inhibition of SARS-CoV-2 infection in human airway epithelium with a xeno-nucleic acid aptamerSemantic proximity Read

DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.Semantic proximity Read

Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agentsSemantic proximity Read

Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19Semantic proximity Read

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**Semantic proximity Read

Elucidating the molecular docking and binding dynamics of aptamers with spike proteins across SARS-CoV-2 variants of concernSemantic proximity Read

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2Semantic proximity Read

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2Semantic proximity Read

De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variantsSemantic proximity Read

Aptamer‐based strategies against SARS‐CoV‐2 virusesSemantic proximity Read